Opendata, web and dolomites

LIPOCOAT SIGNED

Biomimetic nano-coatings for healthcare. Targeting the contact lenses market

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LIPOCOAT project word cloud

Explore the words cloud of the LIPOCOAT project. It provides you a very rough idea of what is the project "LIPOCOAT" about.

wetting    vitro    body    clear    bio    recovered    10    million    forecast    preventing    first    fifth    comfort    2019    inspired    lipid    benefits    roi    biomedical    95    vivo    initial    demo    interaction    neutral    cells    industrialization    efficiency    adhesion    bacterial    proprietary    national    natural    international    fluids    cagr    outside    commercial    biofouling    surface    device    flow    coating    cash    bacteria    prevent    business    deposits    bilayers    contact    fast    32    sales    medical    molecules    projected    improvement    extremely    performance    opportunity    16    cls       billion    ties    biomolecules    11    view    layers    decided    close    attract    patented    2014    lubricity    time    coatings    global    found    estimates    market    demonstrated    lipocoat    commercialization    manufacturers    bodily    investment    manufacturing    2020    cell    nano    lenses    placed    water    biocompatible    launching    stably    proteins    cumulative   

Project "LIPOCOAT" data sheet

The following table provides information about the project.

Coordinator
LIPOCOAT BV 

Organization address
address: DRIENERLOLAAN 5
city: ENSCHEDE
postcode: 7522 NB
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://www.lipocoat.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIPOCOAT BV NL (ENSCHEDE) coordinator 50˙000.00

Map

 Project objective

Biofouling, i.e. the formation of deposits of biomolecules or even bacteria in the surface of the medical device, is the main cause of the loss of the devices performance. LipoCoat’s patented nano-coatings make use of lipid bilayers to prevent biofouling of medical devices when placed into contact with bodily fluids in- or outside of the body. Our natural and bio-inspired coating makes use of molecules found in every cell, making it extremely biocompatible. The neutral LipoCoat molecules can efficiently attract water thus preventing any interaction with proteins and cells. Furthermore, LipoCoat can stably apply these layers using our proprietary LipoCoat FAST manufacturing process. Among the wide range of biomedical applications for LipoCoat nano-coatings, we decided to target the contact lenses as it presents a clear business opportunity (a € 11.4 billion global market with a projected CAGR of 7-10% 2014-2019). Demo studies, both in vitro and in vivo, have demonstrated the LipoCoat coating efficiency and its benefits on contact lenses: 95% reduction in bacterial adhesion, improved wetting and lubricity and comfort improvement. In view of these promising results, we were able to establish close ties with leading national and international CLs manufacturers.

The next step for LipoCoat’s commercial success on the contact lenses market, which comprises the main objective of this project, is the industrialization of our proprietary manufacturing process to scale-up the production of LipoCoat nano-coatings. We expect a time-to-market of 2 years, launching our product on the CLs market by 2020. Our initial sales forecast estimates a cumulative cash flow of € 32.2 million after the five first years of commercialization. The estimated investment needed, € 2 million, will be recovered after only two years, and the estimated ROI after the fifth commercialization year is 16.2%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIPOCOAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIPOCOAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

CGM (2018)

A next generation nano media tailored to capture and recycle hazardous micropollutants in contaminated industrial wastewater.

Read More  

STAR (2018)

Safe, Transparent, Active and Reliable mineral sunscreen technology

Read More